SCHEMBL9304098

SCHEMBL9304098

O=C(CCc1cccc(Br)c1)NCCc1c[nH]c2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.67
KMT2A Q03164 3/20 0.67
GOT1 P17174 2/20 0.65
AANAT Q16613 1/20 0.63
GFER P55789 1/20 0.62
MTNR1A P48039 2/20 0.61
GSK3B P49841 1/20 0.58
MMP9 P14780 1/20 0.57
LMNA P02545 1/20 0.56
CYP1A2 P05177 1/20 0.56
PKM P14618 1/20 0.56
TSHR P16473 1/20 0.56
CYP2C19 P33261 1/20 0.56
BLM P54132 1/20 0.56
ALDH1A1 P00352 1/20 0.55
GLA P06280 1/20 0.55
HSD17B2 P37059 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7839075 0.89 MEN1 (0.65) MEN1KMT2AGOT1AANATGFER
SCHEMBL9302255 0.88 GFER (0.70) MEN1KMT2AAANATGFERMTNR1A
SCHEMBL9117842 0.87 MEN1 (0.76) MEN1KMT2AAANATGFERMTNR1A
SCHEMBL7677886 0.84 MEN1 (0.84) MEN1KMT2AAANATGFERMTNR1A
SCHEMBL9304042 0.84 KMT2A (0.67) MEN1KMT2AGFERMTNR1A
SCHEMBL7852138 0.82 GFER (0.69) MEN1KMT2AAANATGFERMTNR1A
SCHEMBL7852879 0.82 GFER (0.84) MEN1KMT2AAANATGFERMTNR1A
SCHEMBL12009643 0.81 GFER (0.91) MEN1KMT2AAANATGFERMTNR1A
SCHEMBL1520606 0.81 IDO1 (0.61) MEN1KMT2AGOT1AANATMMP9
SCHEMBL4536522 0.81 AANAT (0.80) MEN1KMT2AAANATGFERMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5283343-A Melatonin antagonists WHITBY RESEARCH, INC. (US) 1994-02-01 US disclosed
US-5093352-A Melatonin inhibitor, sleep, 2-aryl N-acetyl tryptamine WHITBY RESEARCH, INC. (US) 1992-03-03 US disclosed